Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer.
about
Chemotherapy for newly diagnosed inoperable brain metastases from non-small cell lung cancerBone and brain metastasis in lung cancer: recent advances in therapeutic strategiesCombining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-AnalysisResection versus radiosurgery for patients with brain metastases.Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.Current approaches to the treatment of metastatic brain tumours.Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors.Advantages of a unique DNA-based vaccine in comparison to paclitaxel in treatment of an established intracerebral breast cancer in mice.Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis.Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases.Chemotherapy and targeted molecular therapies for brain metastases.Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma.Icotinib as initial treatment in lung adenocarcinoma patients with brain metastasesChemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients.Oligometastatic non-small-cell lung cancer: current treatment strategies.Systemic treatment of non-small cell lung cancer brain metastasesEGFR mutation status in brain metastases of non-small cell lung carcinoma.EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer.Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.Brain metastasis: new opportunities to tackle therapeutic resistance.Systemic therapy of brain metastases.Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy.Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future.State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.CNS metastasis secondary to malignant-mixed Müllerian tumor: case report and review of therapeutics.Activity of pemetrexed-based regimen as first-line chemotherapy for advanced non-small cell lung cancer with asymptomatic inoperable brain metastasis: a retrospective study.[Clinical Experience of Gefitinib in the Treatment of 32 Lung Adenocarcinoma Patients with Brain Metastases].[Progress of treatments in non-small cell lung cancer with brain metastases].Chemotherapy in brain metastases of lung and breast cancer
P2860
Q24194415-282B6AAA-769E-44CA-AC81-C622ED2B0125Q24568071-BF1B037A-E449-48A6-A12A-F24E1A1B7930Q26752378-7C8BDEFA-FBD8-451D-AAB0-A619BBD39512Q31097790-8AC8A2FB-891A-40F5-88D9-89280B5E8C9DQ33386298-0C17A12E-7262-43D8-82ED-F246EEE8C8B3Q33696559-2380ACE1-99B6-447D-A361-F0CC73B4D820Q34872345-B95E7B76-E2ED-42E5-B222-E8D220F3D5B2Q34977081-1F02A714-96FD-4764-A7D4-CA751605F47DQ35962441-55094302-9D98-4D7D-B81F-233A175C7A5EQ36140948-50EE8A6D-5E1E-4315-893A-2A781FD6D528Q36641504-4B1BADC9-E05A-4174-8D0C-2AF233AA5444Q36924484-2AF513DC-4B66-44C1-8B2B-D4053BF2BFE6Q37060391-49BF3A6D-5E7E-44E7-AFBB-6CF39CD21D6AQ37391069-414B1985-EE78-45CC-80F6-0200C06C28AFQ37643566-6B81090E-B8BA-4569-9068-8316BDA1C18DQ37727648-15F53913-C88A-4724-83FF-83B5CB6F5344Q38053963-13A6B5D1-326F-429E-85F8-4D83AD393D68Q38068204-29791172-3442-4E80-838C-1E98C53B56A2Q38096437-8A92542E-4C50-4DB2-96C3-BEFBC52891EAQ38222247-D5BC6640-9220-4D85-9CCC-433CD97A03DCQ38285931-38AECA72-0336-4169-B15F-E2177DAF4EEFQ38763104-F3E775BF-9251-459A-B738-BD51F6AB8219Q38763111-DC09658A-6F18-4CFC-A3C5-D91C1C128BEBQ38985340-F6459D12-B88D-49EF-8B7F-F44A950B9B1BQ40308252-B9FA075B-3387-4CEE-B570-5A5E96A10A1FQ48027897-C92D9BA2-A0BF-4D60-8998-CF775E87058DQ48299342-65D21519-2AB2-47FD-8F7F-92941078E84BQ53340641-88B1F6DC-C8FB-463D-9BAA-22718652CC7DQ54509712-5E9CFB3E-A601-43B5-AA6F-F72C87EF3B30Q58297721-7FD70323-0467-4D96-B36B-E38447329F16
P2860
Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Front-line paclitaxel/cisplati ...... om non-small-cell lung cancer.
@ast
Front-line paclitaxel/cisplati ...... om non-small-cell lung cancer.
@en
type
label
Front-line paclitaxel/cisplati ...... om non-small-cell lung cancer.
@ast
Front-line paclitaxel/cisplati ...... om non-small-cell lung cancer.
@en
prefLabel
Front-line paclitaxel/cisplati ...... om non-small-cell lung cancer.
@ast
Front-line paclitaxel/cisplati ...... om non-small-cell lung cancer.
@en
P2093
P50
P356
P1433
P1476
Front-line paclitaxel/cisplati ...... rom non-small-cell lung cancer
@en
P2093
Alfonso Gurpide
Angela Claver
Antonio Brugarolas
Emiliano Calvo
Esteban Salgado
Javier Rodriguez
Jesus Garcia-Foncillas
Jose Manuel Aramendia
Salvador Martin-Algarra
P356
10.1159/000066520
P577
2003-01-01T00:00:00Z